| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:CK 3197
CAS:132523-92-3
Package:50mg/RMB 18300;25mg/RMB 13900;100mg/RMB 23500
|
CK 3197 manufacturers
- CK 3197
-
- $2580.00
-
2026-04-20
- CAS:132523-92-3
- Purity:
- Supply Ability: 10g
|
| | CK 3197 Basic information |
| Product Name: | CK 3197 | | Synonyms: | CK 3197;1-Benzoyl-4-ethyl-5-[4-(2-methyl-2-imidazolin-1-yl)benzoyl]-1H-imidazol-2(3H)-one;2H-Imidazol-2-one, 1-benzoyl-5-[4-(4,5-dihydro-2-methyl-1H-imidazol-1-yl)benzoyl]-4-ethyl-1,3-dihydro- | | CAS: | 132523-92-3 | | MF: | C23H22N4O3 | | MW: | 402.45 | | EINECS: | | | Product Categories: | | | Mol File: | 132523-92-3.mol |  |
| | CK 3197 Chemical Properties |
| density | 1.29±0.1 g/cm3(Predicted) | | pka | 9.21±0.70(Predicted) |
| | CK 3197 Usage And Synthesis |
| Description | CK 3197 is a selective positive inotropic agent for the treatment of congestive heart failure. It has hemodynamic and myocardial energetic effects. | | Uses | CK-3197 is a weak inhibitor of Peak lll cyclic 3'5'-adenosine monophosphate phosphodiesterase
(CAMP PDEl). CK-3197 has hemodynamic and myocardial energetic effects in vivo. CK-3197 is an imidazolone derivative used as a selective positive inotropic agent for congestive heart failure[1]. | | References | [1] Greenberg S, et al. Hemodynamic and myocardial energetic effects of CK-3197, a selective positive inotropic agent. J Cardiovasc Pharmacol. 1991 Jan;17(1):145-53. DOI:10.1097/00005344-199101000-00021 |
| | CK 3197 Preparation Products And Raw materials |
|